Novo CEO pressed by Senate to cut prices of weight problems, diabetic issues prescription drugs CEO Lars Fruergaard Jørgensen told lawmakers the organization would contemplate new talks with insurers with regards to the listing charges of Wegovy and copyright if they pledge to keep the medicines on their own formularies. https://kethek.com/